- Abstract:
-
UNLABELLED: The epidermal growth factor receptor (EGFR) is an attractive target for the design of radiotherapeutic agents for breast cancer because it is present on almost all estrogen receptor-negative, hormone-resistant tumors with a poor prognosis. In this study, we describe the antitumor effects and normal tissue toxicity of the novel Auger electron-emitting radiopharmaceutical (111)In-labeled diethylenetriaminepentaacetic acid-human epidermal growth factor ((111)In-DTPA-hEGF) administer...
Expand abstract - Publication status:
- Published
- Journal:
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine
- Volume:
- 44
- Issue:
- 9
- Pages:
- 1469-1478
- Publication date:
- 2003-09-05
- EISSN:
-
1535-5667
- ISSN:
-
0161-5505
- URN:
-
uuid:00221e93-cfae-4966-9418-f7e123b3ffdf
- Source identifiers:
-
130909
- Local pid:
- pubs:130909
- Language:
- English
- Keywords:
- Copyright date:
- 2003
Journal article
Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
If you are the owner of this record, you can report an update to it here: Report update to this record